BBIO: Wutah pendapatan triwulanan BridgeBio Pharma, Inc.

BridgeBio Pharma, Inc. (BBIO) - logo korporat

BridgeBio Pharma, Inc. (BBIO) invests in identifying the molecular causes of rare pathologies through deep R&D. This quarterly revenue growth chart illustrates the dynamics of these processes, where the metric stands at 192.20. By holding patents for the treatment of rare mutations, BridgeBio Pharma, Inc. (BBIO) secures its own pricing power. The stability of this progress is supported by the diversification of contracts for the supply of critical research components.

BBIO Tambahing pendapatan triwulanan BridgeBio Pharma Inc (04.07.2022 - 20.11.2026)

Ringkesan rincian data analitis BridgeBio (BBIO)

Pambiji fundamental perusahaan:BBIO - BridgeBio Pharma, Inc.
Produk sing diprodhuksi bridgebio.com

For BridgeBio Pharma, Inc. (BBIO), which develops high-cost drugs for orphan diseases, analyzing sales dynamics is critical for assessing product commercialization. This metric measures the percentage change in revenue for the current quarter compared to the same period last year, revealing the pace of business scaling. Through this quarterly revenue chart, investors track the stability of cash flows after obtaining exclusive marketing rights. Peak values of this indicator may signal that growth momentum is exhausting, warning of the risk of overpaying for the asset.

Perusahaan pesaing

Vertex Pharmaceuticals - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan ALNY (Alnylam Pharmaceuticals)|INSM: Wutah pendapatan triwulanan|United Therapeutics Corp (UTHR) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BioMarin Pharma|Wutah dodolan triwulanan BGM Group Ltd (BGM)|Wutah pendapatan kuartal marang kuartal cogentbio.com (COGT)|Wutah dodolan triwulanan Xeris Biopharma XERS|Wutah pendapatan triwulanan KROS (kerostx.com)|Wutah pendapatan triwulanan Arcturus Therapeutics Holdings Inc. ARCT|etonpharma.com - Wutah pendapatan triwulanan|KMDA - Wutah pendapatan triwulanan|FULC (Fulcrum Corp) - Wutah dodolan triwulanan|ABEO (Abeona Therapeutics, Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal mereobiopharma.com|PLX (Protalix BioTherapeutics, Inc.) - Owah-owahan dodolan kuartal marang kuartal|Wutah pendapatan triwulanan PLRX|Wutah pendapatan kuartal marang kuartal APLT (Applied Therapeutics)|Rein Therapeutics Inc - Wutah dodolan triwulanan|Gelteq Limited (GELS) - Tingkat wutah pendapatan sajrone kuartal|aytubio.com - Wutah pendapatan triwulanan|chemomab.com (CMMB) - Wutah dodolan triwulanan|SRXH: Wutah pendapatan triwulanan|Dinamika pendapatan kuartal marang kuartal PLRZ (Polyrizon Ltd.)|Wutah dodolan triwulanan AEZS|CYTH: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal inozyme.com (INZY)|Wutah pendapatan triwulanan Reneo Pharmaceuticals Inc. (RPHM)|Wutah pendapatan triwulanan CSCI (Aeterna Zentaris)